Low-cost urine tenofovir assay to triage dolutegravir resistance testing

Lancet HIV. 2024 May;11(5):e282-e283. doi: 10.1016/S2352-3018(24)00060-2. Epub 2024 Mar 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Drug Resistance, Viral*
  • HIV Infections* / drug therapy
  • HIV Infections* / virology
  • HIV Integrase Inhibitors / therapeutic use
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • Heterocyclic Compounds, 3-Ring* / therapeutic use
  • Humans
  • Oxazines*
  • Piperazines*
  • Pyridones*
  • Tenofovir* / therapeutic use

Substances

  • dolutegravir
  • Pyridones
  • Oxazines
  • Heterocyclic Compounds, 3-Ring
  • Piperazines
  • Tenofovir
  • HIV Integrase Inhibitors
  • Anti-HIV Agents